Understanding Barriers and Facilitators to the Participation of Women Living With HIV in Clinical Trials : a Mixed-method Study (EVA)

Understanding Barriers and Facilitators to the Participation of Women Living With HIV in Clinical Trials : a Mixed-method Study (EVA)

To identify the most important barriers and facilitators to the participation of cisgender women living with HIV in clinical trials (perceived and real) and to establish possible mechanisms leading to refusal of trial participation. Specifically, psychosocial factors and/or cultural environments that enhance or undermine HIV-positive cisgender women's participation. These can include social inclusion, confidence in research, perceived personal vulnerability, cultural, familial and professional environment.

The investigators expect to propose pragmatic solutions to enhance participation of HIV-positive cisgender women in clinical trials.

Inclusion Criteria:

• Cisgender women
• Adult (>18 years) HIV-infected
• Informed consent documented by signature
• Patients under stable antiretroviral therapy
• French speaking (sufficient fluency for a conversation)

Exclusion Criteria:

• Having participated in a previous qualitative study about Cure Trials acceptability among HIV patients
• Incapable of discernment